Insmed Incorporated (INSM) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Insmed Incorporated, updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$96.98
+2.13% today
Market cap
$20.7B
Overall quality
—
Kronos AI 30-day
+13.0%
8 of 8 simulated paths end higher
Insmed Incorporated (INSM) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $20.7B. It trades at $96.98, up 2.13% today. 21 analysts' average target of $196.16 implies +102.3% from today's price. Kronos AI's 30-day forecast is +13.0% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $196.16 |
| Low – high | $169.00 – $243.00 |
| Analysts | 21 |
| Upside to average | +102.3% |
Kronos AI 30-day forecast
| Expected close | $107.28 (+13.0%) |
| Likely range | +8.6% … +21.7% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.